Bryant Moeller

Compared with patients with a negative CT, patients with chronic thromboembolic pulmonary hypertension tended to have lower dual-energy computed tomography-based parenchymal attenuation in Hounsfield unit.

Compared with the low dose, high-dose subcutaneous treprostinil increased 6-minute walk distances in patients with chronic thromboembolic pulmonary hypertension.

Natriuretic peptides and high-sensitive troponin may be useful for cardiac risk stratification in acute syncope.

The effects of using high-sensitivity cardiac troponin I assays in patients with suspected acute coronary syndrome were assessed.

HbA1c levels following left ventricular assist device implantation were statistically significantly lower than before surgery.

Healthy nonmenopausal women taking oral contraceptives exhibited biomarkers for drug-induced torsade de pointes.

Individuals who would now be classified as having stage 1 hypertension according to the new American College of Cardiology/American Heart Association blood pressure guidelines also have an increased risk for cardiovascular events.

Ticagrelor without aspirin offered no additional benefits compared with conventional dual antiplatelet therapy in patients undergoing PCI for either CAD or ACS.

Net adverse cardiac events occurred in 15.2% of patients with radial access and 17.2% with femoral access while undergoing invasive therapies for acute coronary syndrome.

A guideline-based approach directing pharmacological treatment to adults more likely to have CVD events may maximize absolute risk reduction of treatment.